For those with kidney failure, the wait for a new kidney can take years. There just are not enough organs from deceased ...

In Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month ...

New Hampshire native Tim Andrews was quite happy to spend his 67th birthday on Wednesday at Mass General Hospital (MGH). On ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

The former prom dates hadn’t been in touch in decades, but Elena Hershey decided to donate her kidney when she heard about ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Dell Seton Medical Center opened a new, expanded clinic for its Adult Abdominal Transplant Center, which aims to provide ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

NEW YORK, March 5, 2025 /PRNewswire/ -- Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived ...